ALKERMES PLC's ticker is ALKS and the CUSIP is G01767105. A total of 200 filers reported holding ALKERMES PLC in Q3 2019. The put-call ratio across all filers is 0.23 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $41,945,003 | -19.2% | 1,497,501 | -9.7% | 0.02% | -19.2% |
| Q2 2023 | $51,927,670 | +73040.7% | 1,659,031 | -34.1% | 0.03% | -36.6% |
| Q1 2023 | $70,997 | -20.7% | 2,518,518 | -26.5% | 0.04% | -18.0% |
| Q4 2022 | $89,571 | -99.7% | 3,427,885 | +164.9% | 0.05% | +194.1% |
| Q3 2022 | $28,895,000 | +44.6% | 1,294,008 | +92.9% | 0.02% | +41.7% |
| Q2 2022 | $19,981,000 | +235.8% | 670,740 | +196.6% | 0.01% | +300.0% |
| Q1 2022 | $5,950,000 | -21.7% | 226,147 | -30.8% | 0.00% | -25.0% |
| Q4 2021 | $7,599,000 | +730.5% | 326,682 | +1001.3% | 0.00% | +300.0% |
| Q3 2021 | $915,000 | -95.1% | 29,662 | -96.1% | 0.00% | -90.9% |
| Q2 2021 | $18,576,000 | +23.3% | 757,567 | -6.1% | 0.01% | 0.0% |
| Q1 2021 | $15,069,000 | +156.1% | 806,708 | +173.6% | 0.01% | +175.0% |
| Q4 2020 | $5,883,000 | +65.8% | 294,864 | +37.7% | 0.00% | 0.0% |
| Q3 2020 | $3,548,000 | -81.7% | 214,151 | -78.6% | 0.00% | -85.2% |
| Q2 2020 | $19,429,000 | -28.5% | 1,001,225 | -46.9% | 0.03% | -55.7% |
| Q1 2020 | $27,188,000 | +18.2% | 1,885,442 | +67.2% | 0.06% | +110.3% |
| Q4 2019 | $23,005,000 | -49.2% | 1,127,720 | -51.5% | 0.03% | -59.7% |
| Q3 2019 | $45,326,000 | +170.8% | 2,323,270 | +212.9% | 0.07% | +188.0% |
| Q2 2019 | $16,736,000 | -14.8% | 742,505 | +37.9% | 0.02% | -16.7% |
| Q1 2019 | $19,641,000 | -28.5% | 538,266 | -42.2% | 0.03% | -28.6% |
| Q4 2018 | $27,486,000 | +31.8% | 931,405 | +89.5% | 0.04% | +68.0% |
| Q3 2018 | $20,857,000 | +461.1% | 491,452 | +444.3% | 0.02% | +400.0% |
| Q2 2018 | $3,717,000 | -41.2% | 90,295 | -17.2% | 0.01% | -37.5% |
| Q1 2018 | $6,320,000 | +315.2% | 109,038 | +292.1% | 0.01% | +300.0% |
| Q4 2017 | $1,522,000 | -88.0% | 27,807 | -88.8% | 0.00% | -89.5% |
| Q3 2017 | $12,651,000 | -85.1% | 248,841 | -83.0% | 0.02% | -87.5% |
| Q2 2017 | $85,002,000 | -10.0% | 1,466,313 | -9.2% | 0.15% | -12.1% |
| Q1 2017 | $94,483,000 | -6.7% | 1,615,088 | -11.3% | 0.17% | -18.4% |
| Q4 2016 | $101,236,000 | +2075.7% | 1,821,450 | +1741.0% | 0.21% | +2550.0% |
| Q3 2016 | $4,653,000 | -81.5% | 98,939 | -86.5% | 0.01% | -87.3% |
| Q1 2016 | $25,104,000 | +62.5% | 734,242 | +277.2% | 0.06% | +96.9% |
| Q4 2015 | $15,452,000 | +265.6% | 194,664 | +170.3% | 0.03% | +300.0% |
| Q3 2015 | $4,226,000 | -84.5% | 72,026 | -83.0% | 0.01% | -84.3% |
| Q2 2015 | $27,202,000 | +9.7% | 422,787 | +3.9% | 0.05% | +10.9% |
| Q1 2015 | $24,805,000 | +44.9% | 406,839 | +39.1% | 0.05% | +27.8% |
| Q4 2014 | $17,121,000 | +106.2% | 292,375 | +50.9% | 0.04% | +71.4% |
| Q3 2014 | $8,305,000 | +295.7% | 193,727 | +364.4% | 0.02% | +250.0% |
| Q2 2014 | $2,099,000 | -52.3% | 41,714 | -58.2% | 0.01% | -53.8% |
| Q1 2014 | $4,396,000 | +43.9% | 99,707 | +32.7% | 0.01% | +30.0% |
| Q4 2013 | $3,054,000 | -78.3% | 75,117 | -82.0% | 0.01% | -77.8% |
| Q3 2013 | $14,048,000 | -38.4% | 417,849 | -47.4% | 0.04% | -35.7% |
| Q2 2013 | $22,794,000 | – | 794,756 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Woodford Investment Management Ltd | 2,639,676 | $96,322,000 | 7.78% |
| Meditor Group Ltd | 892,400 | $32,564,000 | 6.11% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 233,000 | $8,502,000 | 3.14% |
| Tamarack Advisers, LP | 140,000 | $5,109,000 | 2.03% |
| Asymmetry Capital Management, L.P. | 27,673 | $1,010,000 | 1.69% |
| First Light Asset Management, LLC | 211,164 | $7,705,000 | 1.00% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 304,992 | $11,129,000 | 0.85% |
| Nicollet Investment Management, Inc. | 28,020 | $1,022,000 | 0.67% |
| PRIMECAP MANAGEMENT CO/CA/ | 23,263,530 | $848,886,000 | 0.62% |
| Rhenman & Partners Asset Management AB | 120,399 | $4,393,000 | 0.51% |